These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 16249432)

  • 1. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
    Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
    Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
    Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
    Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
    Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
    Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
    Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
    J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes.
    Yu Y; Thorpe SR; Jenkins AJ; Shaw JN; Sochaski MA; McGee D; Aston CE; Orchard TJ; Silvers N; Peng YG; McKnight JA; Baynes JW; Lyons TJ;
    Diabetologia; 2006 Oct; 49(10):2488-98. PubMed ID: 16955213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
    Monnier VM; Genuth S; Sell DR
    Glycoconj J; 2016 Aug; 33(4):569-79. PubMed ID: 27342131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
    Beisswenger PJ; Makita Z; Curphey TJ; Moore LL; Jean S; Brinck-Johnsen T; Bucala R; Vlassara H
    Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
    Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
    Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
    Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
    Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
    J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
    Monnier VM; Sell DR; Gao X; Genuth SM; Lachin JM; Bebu I;
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35058313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
    Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
    Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
    Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
    Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
    McCance DR; Dyer DG; Dunn JA; Bailie KE; Thorpe SR; Baynes JW; Lyons TJ
    J Clin Invest; 1993 Jun; 91(6):2470-8. PubMed ID: 8514859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
    Sell DR; Lapolla A; Odetti P; Fogarty J; Monnier VM
    Diabetes; 1992 Oct; 41(10):1286-92. PubMed ID: 1397702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.